Table 3 Complications, long-term outcomes and costs of the Xi and Si groups
From: A comparison of the da Vinci Xi vs. da Vinci Si surgical systems for radical prostatectomy
Variables | Xi (n = 82) | Si (n = 93) | p value |
|---|---|---|---|
Postoperative complications, n (%) | |||
Clavien < 3 | 17 (20.7) | 22 (23.7) | 0.717 |
Clavien ≥ 3 | 4 (4.9) | 7 (7.5) | 0.545 |
Urethral stricture, n (%) | 8 (9.8) | 9 (9.7) | 1.000 |
Continence, n (%) | |||
First month | 51 (62.2) | 55 (59.1) | 0.757 |
Third month | 72 (87.8) | 82 (88.2) | 1.000 |
Sixth month | 77 (93.9) | 86 (92.5) | 0.772 |
Follow-up, mean (SD), month | 8.7 (1.7) | 8.2 (1.7) | 0.051 |
Positive margin, n (%) | 44 (53.7) | 56 (60.2) | 0.445 |
Biochemical recurrence, n (%) | 20 (24.4) | 23 (24.7) | 1.000 |
Total cost of hospitalization, mean (SD), ¥ | 84,740.7 (16,531.2) | 76,739.1 (17,852.9) | 0.003 |
Cost of intraoperative consumables, median (range), ¥ | 13,199.4 (4986, 34,121) | 10,823 (5340, 20,784) | 0.019 |